A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension

Launched by QILU PHARMACEUTICAL CO., LTD. ·

Keywords

ClinConnect Summary

This clinical trial is studying a new medicine called QLS1410 to see if it is safe and well-tolerated in healthy adults and people with mild high blood pressure (also called mild essential hypertension). The researchers want to understand how the body processes the medicine, how the medicine affects the body, and whether eating food changes how the medicine works. This study is an early phase trial, meaning it focuses mainly on safety and how the drug behaves in the body rather than on how well it treats high blood pressure.

People who may be able to join this trial are healthy Chinese adults or those with mild high blood pressure. The trial will include adults of all genders, but the age range listed seems unclear and may need confirmation. Participants will receive different amounts of QLS1410, either one time or multiple times, and the researchers will closely monitor their health and any side effects. It’s important to know that this study is not yet recruiting participants, so those interested should keep an eye out for updates from the research team.

Gender

ALL

Eligibility criteria